Association of SLC polymorphism and chemotherapy
response
Correlation between SLC polymorphism and the effectiveness of
response rate and clinical benefits were studied using univariate
logistic regression. Supplementary Table 4 shows the
relationship between SLC Â polymorphism and treatment responses.The
individuals showing stable and progressive disease were categorized as
non-responders, whereas subjects demonstrating complete or partial
response were classified as good responders. Our outcomes showed no
association between SLC polymorphisms according to the
chemotherapeutic response to platinum-based doublet therapy. As a
result, we concluded that none of the SLCÂ polymorphisms might predict
chemotherapeutic response or clinical benefit in a significant way.